A blood-based approach could enable personalized immunotherapy without the need for a tumor biopsy

Medical Xpress - latest medical and health news stories ·
Health & Medicine United Kingdom

In a study published in Cancer Discovery, cancer neoantigens and neoantigen-specific T cells were identified from patient blood samples by analyzing circulating tumor DNA (ctDNA) and immune cells.

Read original article on Medical Xpress - latest medical and health news stories →